肝肿瘤射频消融严重并发症的可能机理与预防策略
Possible Mechanism and Prophylaxis Strategy of Severe Complication in Radiofrequency Ablation Treatment on Liver Tumor
DOI: 10.12677/WJCR.2013.32002, PDF, HTML, XML,  被引量    国家科技经费支持
作者: 姜凯*：解放军总医院，中国人民解放军肝胆外科研究所肝胆外科，北京；顾万清：
关键词: 微创治疗；肝肿瘤；射频消融；并发症；机理；理论；假设；预防；Minimally Invasive Therapy; Liver Tumor; RFA; Complication; Mechanism; Theory; Hypothesis; Prevention
摘要: 微创治疗与治疗结果的统一，才是真正意义上的微创治疗。严重并发症的发生，将使微创治疗失去本身的意义。肝脏肿瘤射频消融(radiofrequency ablation, RFA)作为有效的微创治疗手段，它的治疗的实施过程，同时也是预防并发症的过程，应该从根本上认识严重并发症的机理，并在治疗过程随时进行预防。本文就RFA治疗的严重并发症，进行发生机理的探讨与理论假设，以期待进一步研究与尽最大可能避免它们的发生。  The fundament of real minimally invasive therapy lies on the consistency of minimally invasive approach and anticipatory efficacy, while occurrence of serious complication would heavily shake the base. However, by acquainting with the mechanism in occurrence of serious complications, prevention can be taken during the process of treatment. As one of the effective minimally invasive therapies for liver tumors, the procedure of radiofrequency ablation (RFA) takes both treatment for tumors and prevention of complications in consideration. This article will focus on exploring the possible mechanism and theory of hypothesis of complications during RFA approach, anticipating doing favor to further research on avoiding the serious consequence as far as possible.

 

文章引用：姜凯, 顾万清. 肝肿瘤射频消融严重并发症的可能机理与预防策略[J]. 世界肿瘤研究, 2013, 3(2): 9-12. http://dx.doi.org/10.12677/WJCR.2013.32002

参考文献

[1] [1] T. Livraghi, L. Solbiati, M. F. Meloni, G. S. Gazelle, E. F. Halpern and S. N. Goldberg. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications en- countered in a multicenter study. Radiology, 2003, 226(2): 441- 451.
[2] L. X. Liu, H. C. Jiang and D. X. Piao. Radiofrequence ablation of liver cancers. World Journal of Gastroenterology, 2002, 8(3): 393-399.
[3] B. Topal, D. Hompes, R. Aerts, S. Fieuws, M. Thijs and F. Penninckx. Morbidity and mortality of laparoscopic vs. open radiofrequency ablation for hepatic malignancies. European Journal of Surgical Oncology, 2007, 33(5): 603-607.
[4] J. L. Soon, P. R. Jeyaraj and T. Agasthian. Thoracic complications of radiofrequency ablation of recurrent hepatoma. Annals of the Academy of Medicine, Singapore, 2008, 37(1): 75-76.
[5] I. Song, H. Rhim, H. K. Lim, Y. S. Kim and D. Choi. Per- cutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: Safety and technical efficacy in 143 patients. European Radiology, 2009, 19(11): 2630-2640.
[6] P. Hildebrand, M. Kleemann, U. Roblick, L. Mirow, M. Birth and H. P. Bruch. Laparoscopic radiofrequency ablation of un- resectable hepatic malignancies: Indication, limitation and re- sults. Hepatogastroenterology, 2007, 54(79): 2069-2072.
[7] P. Hildebrand, T. Leibecke, M. Kleemann, L. Mirow, M. Birth, H. P. Bruch and C. Bürk. Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome. European Journal of Surgical Oncology, 2006, 32(4): 430-434.
[8] J. L. Soon, P. R. Jeyaraj and T. Agasthian. Thoracic com- plications of radiofrequency ablation of recurrent hepatoma. Annals of the Academy of Medicine, Singapore, 2008, 37(1): 75-76.
[9] J. Lee, J. M. Lee, J.-H. Yoon, J. Y. Lee, S. H. Kim, J. E. Lee, J. K. Han and B. I. Choi. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular car- cinomas. Korean Journal of Radiology, 2012, 13(1): 34-43.
[10] Z. Q. Huang. Primary intrahepatic stone and its related problems. Chongqing: The 3rd Military College Press, 1962: 48-59.
[11] K. Jiang, M. Su, Y. Liu, et al. Complete radio frequency ablation of hepatocellular carcinoma adjacent to the main bile duct and blood vessels between the first and the second hepatic portal. Cell Biochemistry and Biophysics, 2012, 66(2): 397-402.
[12] S. Rossi, F. Garbagnati, I. De Francesco, F. Accocella, L. Leonardi, P. Quaretti, A. Zangrandi, C. Paties and R. Lencioni. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori, 1999, 85(2): 128-132.
[13] S. N. Goldberg, G. S. Gazelle, S. L. Dawson, W. J. Rittman, P. R. Mueller and D. I. Rosenthal. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol. 1995, 2(5): 399-404.
[14] S. N. Goldberg, G. S. Gazelle, S. L. Dawson, W. J. Rittman, P. R. Mueller and D. I. Rosenthal. Tissue ablation with radiofrequency using multiprobe arrays. Academic Radiology, 1995, 2(8): 670-674.
[15] E. Levit, P. Bruners, R. W. Günther and A. H. Mahnken. Bile aspiration and hydrodissection to prevent complications in hepatic RFA close to the gallbladder. Academic Radiology, 2012, 53(9): 1045-1048.

为你推荐